Uterine leiomyosarcomas: a review of the diagnostic and therapeutic pitfalls
Authors:
- 1 April 2007
- journal article
- review article
- Published by Wiley in The Obstetrician & Gynaecologist
- Vol. 9 (2) , 88-94
Abstract
Key content: Uterine leiomyosarcomas are the most common uterine sarcoma and they are notoriously aggressive in nature. Preoperative diagnosis is difficult and they are usually detected as an incidental finding at surgery. Tumour stage is the most important prognostic factor. Misdiagnosis or delay in diagnosis can occur following the use of conservative techniques for managing uterine fibroids. The primary treatment is surgical, while the role of adjuvant therapy is still to be clearly defined. Learning objectives: To appreciate the diagnostic challenges faced with uterine leiomyosarcomas, especially in view of the similarities with uterine fibroids. To learn about the current views on surgical treatment and adjuvant therapy. To have an understanding of the novel therapies currently under investigation. Ethical issues: Can we offer women conservative non‐surgical treatment for fibroids if we cannot confidently exclude leiomyosarcomas? Please cite this article as: Harry VN, Narayansingh GV, Parkin DE. Uterine leiomyosarcomas: a review of the diagnostic and therapeutic pitfalls. The Obstetrician & Gynaecologist 2007;9:88–94.Keywords
This publication has 53 references indexed in Scilit:
- Uterine leiomyoma versus leiomyosarcoma: a new attempt at differential diagnosis based on their cellular characteristicsHistopathology, 2006
- Prognostic factors and impact of adjuvant chemotherapy for uterine leiomyosarcomaGynecologic Oncology, 2006
- Systemic therapy for advanced uterine sarcoma: A systematic review of the literatureGynecologic Oncology, 2005
- The role of surgery and treatment trends in uterine sarcomaEuropean Journal of Surgical Oncology, 2005
- Uterine sarcomas versus leiomyomas: Gray‐scale and Doppler sonographic findingsJournal of Clinical Ultrasound, 2004
- Adjuvant chemotherapy with cisplatin, ifosfamide, and doxorubicin followed by radiotherapy in localized uterine sarcomas: results of a case-control study with radiotherapy aloneInternational Journal of Gynecological Cancer, 2004
- Preoperative Diagnosis and Treatment Results in 106 Patients with Uterine Sarcoma in Hokkaido, JapanOncology, 2004
- Phase II trial of gemcitabine as second-line chemotherapy of uterine leiomyosarcoma: a Gynecologic Oncology Group (GOG) StudyGynecologic Oncology, 2004
- Phase II Trial of Etoposide in Leiomyosarcoma of the Uterus: A Gynecologic Oncology Group StudyGynecologic Oncology, 1996
- Uterine Leiomyosarcoma and Endometrial Stromal Sarcoma: Lymph Node Metastases and Sites of RecurrenceGynecologic Oncology, 1993